What Blood Tests Are Required During Dapsone Therapy?
At a Glance
Patients taking dapsone for bullous systemic lupus need routine Complete Blood Counts (CBC) and Liver Function Tests (LFTs) to monitor for potential side effects like anemia and liver inflammation. Testing is typically required weekly for the first month, then spaced out as the body adjusts.
In this answer
3 sections
While taking dapsone for bullous systemic lupus erythematosus (BSLE), you will need routine blood tests to ensure the medication is working safely. Dapsone is a highly effective treatment that can dramatically improve your lupus blisters, but it is a powerful medication [1]. Beyond your initial screening for G6PD (glucose-6-phosphate dehydrogenase, an enzyme that protects red blood cells), your doctor will order regular Complete Blood Counts (CBC) and Liver Function Tests (LFTs). These tests are especially crucial during your first 3 to 6 months of therapy because this is when side effects are most likely to appear [2].
Complete Blood Counts (CBC): Checking Your Red Blood Cells
A Complete Blood Count (CBC) is a standard test that measures the different types of cells in your blood. When you take dapsone, this test is used primarily to monitor the health of your red blood cells. As your body breaks down dapsone, it creates byproducts that can place stress on red blood cells [3].
Your doctor will use the CBC to watch for two specific blood-related side effects:
- Hemolytic anemia: This occurs when red blood cells are destroyed faster than your body can replace them [4]. Even if you have normal G6PD levels, dapsone can still cause a mild form of this condition [3]. Your doctor will monitor your hemoglobin levels and reticulocytes (immature red blood cells) to ensure your blood counts remain safe [5]. Between blood tests, you should watch for warning signs such as extreme fatigue, yellowing of the skin or eyes (jaundice), or dark, tea-colored urine, and contact your doctor if these occur [4].
- Methemoglobinemia: Dapsone can alter hemoglobin (the protein in your blood that carries oxygen) so that it holds onto oxygen too tightly instead of releasing it to your tissues [6]. If this happens, you might feel unusually fatigued, short of breath, or notice a bluish tint to your lips or fingertips. A CBC and sometimes a more specific test called co-oximetry can help your care team detect if your blood is carrying oxygen effectively [5]. If you experience a bluish tint to your skin or sudden shortness of breath, seek emergency medical care immediately, as this requires prompt treatment. [7]
Liver Function Tests (LFTs): Protecting Your Liver
Your liver is responsible for processing dapsone, which means it has to work hard while you are on this medication. Liver Function Tests (LFTs) measure specific enzymes and proteins in your blood to ensure your liver is healthy and not becoming inflamed [8]. Elevated liver enzymes on your blood test can alert your doctor to problems before you ever feel symptoms, but you should also watch for physical signs of liver stress, such as right-sided abdominal pain, persistent nausea, or a loss of appetite [9].
Regular LFTs help your doctor monitor for:
- Liver toxicity (hepatotoxicity): In some cases, dapsone can cause drug-induced inflammation in the liver [9].
- Dapsone Hypersensitivity Syndrome (DHS): This is a rare but serious reaction to the medication that typically happens in the first several weeks of treatment [10][11]. It can involve inflammation of internal organs like the liver [8]. Symptoms include a high fever, swollen lymph nodes, and a new rash. Because you already have BSLE blisters, it is important to know that a DHS rash typically looks different—it often appears as widespread, flat redness or peeling (desquamation) rather than fluid-filled blisters [12]. If you develop a fever and this type of new skin reaction, contact your doctor immediately.
What to Expect: The Monitoring Schedule
Because side effects are most common when you first start the medication or increase your dose, your blood test schedule will be front-loaded.
While your specific schedule will depend on your doctor and your unique health profile, a typical dapsone monitoring routine involves [2]:
- First Month: Weekly or bi-weekly CBCs and LFTs to ensure your body is tolerating the new medication.
- Months 2 to 6: Monthly blood tests as your body adjusts to a stable dose.
- Long-term: Once you have been on a stable dose for 6 months without issues, testing is usually spaced out to every 3 to 6 months.
If your blood tests come back slightly abnormal, do not panic. Often, your doctor can simply lower your dapsone dose to resolve the issue rather than stopping the medication entirely [13]. Always attend your scheduled blood draws, as these tests are the easiest way to catch changes in your blood or liver early.
Common questions in this guide
Why do I need frequent blood tests when starting dapsone?
What are the signs of liver stress while taking dapsone?
What should I do if my lips or fingers turn blue while on dapsone?
How do I know if I have Dapsone Hypersensitivity Syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What exact schedule of blood tests do you recommend for me during my first few months on dapsone?
- 2.At what hemoglobin level or liver enzyme level would we need to lower my dapsone dose or stop the medication?
- 3.Can I get these routine blood draws done at a local lab closer to my home, or do I need to come to the clinic?
- 4.How quickly will we get the results of my routine CBC and LFTs, and how will your office communicate them to me?
- 5.How can I best distinguish between my normal lupus blisters and a potential allergic rash from the medication?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Juvenile bullous systemic lupus erythematosus - case report.
Sousa S, Santos MJ
Acta reumatologica portuguesa 2020; (45(1)):74-75.
PMID: 32608382 - 2
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.
Ly KH, Dalmay F, Gondran G, et al.
Medicine 2016; (95(42)):e4974 doi:10.1097/MD.0000000000004974.
PMID: 27759628 - 3
Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
Dziewulska KH, Reisz JA, Hay AM, et al.
The Journal of pharmacology and experimental therapeutics 2023; (386(3)):323-330 doi:10.1124/jpet.123.001634.
PMID: 37348965 - 4
Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Tang ASO, Wong QY, Yeo ST, et al.
The American journal of case reports 2021; (22()):e931655 doi:10.12659/AJCR.931655.
PMID: 34038399 - 5
Dapsone-induced methemoglobinemia-A case report.
Kabir H, Lakshmanan R, Gopinath S, Bhonagiri D
Clinical case reports 2021; (9(5)):e04054 doi:10.1002/ccr3.4054.
PMID: 34084488 - 6
Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis.
Akasaka E, Kayo SJ, Nakano H, et al.
Case reports in dermatology 2015; (7(2)):183-6 doi:10.1159/000438506.
PMID: 26351428 - 7
Dapsone-Induced Methemoglobinemia in a Patient With Multiple Myeloma Following Autologous Stem Cell Transplantation: A Case of Conservative Management.
Weragoda S, Shakya S
Cureus 2025; (17(11)):e96903 doi:10.7759/cureus.96903.
PMID: 41255504 - 8
Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia.
Ezhilarasan D
Drug and chemical toxicology 2021; (44(3)):330-333 doi:10.1080/01480545.2019.1679829.
PMID: 31631707 - 9
Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent.
Quaresma MV, Bernardes Filho F, Hezel J, et al.
Anais brasileiros de dermatologia 2015; (90(3 Suppl 1)):51-4.
PMID: 26312673 - 10
The Dapsone Conundrum: Understanding Implications of Adverse Reactions to Dapsone Including Dapsone Hypersensitivity Syndrome in Leprosy Patients Treated With Multidrug Therapy.
Dev A, Narang T, Thakur V, Dogra S
International journal of dermatology 2025; (64(10)):1862-1869 doi:10.1111/ijd.17906.
PMID: 40514800 - 11
Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC, Palacio AL, Chellini PR, et al.
Leprosy review 2015; (86(2)):186-90.
PMID: 26502691 - 12
Dapsone Hypersensitivity Syndrome With Leukemoid Reaction and Severe Thrombocytosis.
Pahadiya HR, Lakhotia M
Cureus 2021; (13(3)):e14026 doi:10.7759/cureus.14026.
PMID: 33889465 - 13
Methaemoglobinaemia as an Alternative Diagnosis for Shortness of Breath: A Case Report.
Thiri T, San SS, Lwin ZT
Cureus 2025; (17(5)):e83525 doi:10.7759/cureus.83525.
PMID: 40470439
This page provides educational information about blood test monitoring during dapsone therapy. Always consult your rheumatologist or dermatologist regarding your specific lab results and medication schedule.
Get notified when new evidence is published on Rare cutaneous lupus erythematosus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.